Trasylol, or aprotinin, injection is used to minimize blood loss during heart surgery and is administered to aid the body’s ability to prevent bleeding. The use of Trasylol doesn’t stop with surgery. It is also used in blood transfusions for patients who are undergoing cardiopulmonary bypass, and also slows down multiple intermediaries of inflammation, holds back proinflammatory cytokine release, which reduces complement activation, defective thrombin and plasmin-induced platelets. The stabilization of the platelet membranes and preservation of their function rounds out the uses of this drug. Bayer Pharmaceuticals Corporation manufactured the product for those patients who undergo coronary artery bypass grafting to block the enzymes that dissolve blood clots.

In January of 2006, a study submitted to New England Journal of Medicine stated that the use of Trasylol during bypass surgery can double the risk of kidney problems, kidney failure, heart attack, renal failure, encephalopathy (brain tissue damage), stroke, and even death. The makers of Trasylol and the FDA filed letters that involve cautionary actions for the physicians who are using Trasylol in their operations by involving observations on the patients and limiting the use of the product. Since the FDA and Bayer are currently evaluating reports, major side effect reports are reevaluated and a possible banning of the drug is yet to be determined. A recommendation is considered to the physicians’ use of Trasyslol to situations that are necessary and outweighs potential risks.

When the FDA issued a warning statement about a Trasylol’s unanticipated side effects in February of 2006, reactions from different sectors started the drug’s demise. Though the FDA’s statement didn’t instruct physicians to stop using the drug, it came under intense scrutiny. Symptoms of possible reactions after using Trasylol are nausea, dyspnea (difficulty breathing), pallor or cyanosis (loss of skin/mucous membrane), urticaria (allergic reaction resulting to red skin welts), rashes, itching and, sudden drops in blood pressure. A different study concludes that Trasylol caused 11,000 patients worldwide to need kidney dialysis each year. An article released in January 2006 by the New England Journal of Medicine has it that the use of Trasylol increases the risk of heart failure (109%), heart attack (48%) and stroke (181%) among more than 4000 patients.

Concerns about the possible side effects of Trasylol have led a large number of people to file lawsuits for themselves and others. Victims should be handled with significance in a possible banning of the product. If you are suffering after using this drug, you are encouraged to seek the guidance of an attorney concerning your specific inquiry and condition. If you are confident enough to have legal claims regarding about the case, then you have the opportunity to pursue your claim. However, deadlines and decrees of limitation are implemented in certain regions, so victims should file his legal claims immediately.

There are many agencies that are in full support in any of your statements regarding Trasylol. They have attorneys and lawyers who can help you find solutions and provide proper guidance about your claims. Patients who need helping hand should contact them immediately.